Funding body: European Commission - EC
Project title: Understanding vaccination hesitancy and evaluating single dose and genderneutral vaccination for improving uptake of HPV vaccines in West and East Africa.
Principal investigator: Pavón MA
Ref.: 101159996- IMPROVE-HPV
Amount awarded: 251.775,74 EUR
Duration: 2024-2028
State: Awarded

Funding body: Bill and Melinda Gates Foundation
Project title: HPV vaccination and Infectivity Reduction in HPV-positive women (RIFT-TZ).
Principal investigator: Pavón MA
Ref.: INV-074218
Amount awarded: 989.071 EUR
Duration: 2024-2026
State: Awarded

Funding body: INSTITUTO DE SALUD CARLOS III - ISCIII
Project title: Leveraging Genomics and Artificial Intelligence for a Non-Invasive Detection tool for Endometrial Cancer, The Urine Sample Solution (GAIN-EC)
Principal investigator: Costas L
Ref.: PI23/00790
Amount awarded: 134918,38 EUR
Duration: 2024-2026
State: Awarded

Funding body: Merck Sharpe & Dohme de España, S.A.
Project title: Self vs. Clinician: Pioneering HPV Detection in Our Hands. (aSELF-GEN: Anal Self-Sampling for Effective HPV Genotyping)
Principal investigator: Cristina Agustí (CEEISCAT), Paytubi S
Ref.: IISP 101906
Amount awarded: 38.784,14€
Duration: 2024-2025
State: Awarded

Funding body: GEICO
Project title: Mutation analysis of circulating tumor DNA in urine samples for disease monitoring in endometrial cancer
Principal investigator: Costas L
Co-investigators: Ponce J
Amount awarded: 25000 EUR
Duration: 2024-2025
State: Awarded

Project title: Evaluación de un flujo de trabajo automático para la detección de tipos de VPH de alto riesgo oncogénico en muestras cervicovaginales obtenidas mediante automuestreo
Principal investigator: Pavon, MA
Co-investigators: Ibañez, R
Amount awarded: 40.058 EUR
Duration: 2024-2025
State: Awarded

Funding body: Mwanza Internv Trials Unit
Project title: Adding male single dose HPV Vaccination to Female HPV Vaccine
Principal investigator: Pavon, MA
Amount awarded: 106.810 EUR
Duration: 2024-2025
State: Awarded

Funding body: NCI
Project title: Evaluating Differences in Human Papillomavirus Attributable Fraction and Genotype Distribution in Cervical, Anal, Genital and Oropharyngeal Cancers among People with and without HIV infection in South Africa
Principal investigator: Jaimie Z. Shing (Staff scientist) , Adino Tsegaye (Postdoctoral Fellow) , Wenlong Carl Chen
Co-investigators: Loretto Carvajal , Eric Engels, Meredith Shiels, Danping Liu, Siddharth Roy, Sizeka Mashele, Reubina Wadee, Bianca Da Costa Dias, Adam Botha, Abrie van Wyk, Laia Alemany, Miguel Angel Pavon Ribas, Tim Waterboer
Amount awarded: 131.151,64 USD
Duration: 2024-2025
State: Awarded

Funding body: AGAUR
Project title: GRUP SGR Epidemiologia Molecular i Genètica en Infeccions i Càncer (EMG)
Principal investigator: Alemany L
Ref.: 2021SGR01354
Amount awarded: 58847,19 EUR
Duration: 2023-2025
State: Awarded

Funding body: Fundació Leitat
Project title: Leveraging Genomics and AI for Non-Invasive Detection of Endometrial Cancer, a Urine Sample Solution: GAIN-EC
Principal investigator: Costas L
Ref.: CIMTI Challenge Call 2023
Amount awarded: 0 EUR
Duration: 2023-2025
State: Awarded

Funding body: CIBER
Project title: Novel non-invasive test to early detect endometrial cancer based on genomic exploitation and microscopy imaging of urine samples
Principal investigator: Costas L, Salamanca-Fernandez E
Co-investigators: Alemany L, Olea N, Matias-Guiu X, Capellà G, Dobaño C, et al
Amount awarded: 50000 EUR
Duration: 2023-2024
State: Awarded

Funding body: Tampere University
Project title: Testing of oral gargle samples from population engaged in a community clinical trial.
Principal investigator: Alemany, L
Amount awarded: 42.438,93 EUR
Duration: 2024-2024

Funding body: Seegene
Project title: Speaker contract IPVS Edinburgh
Principal investigator: Pavón MA
Ref.: Seegene’s industrial symposium during the IPVC Conference (including the round table discussion after the presentation, the preliminary meeting and follow-up meetings)
Amount awarded: 0€
Duration: 2024-2024

Funding body: MSD España
Project title: Reduction of VIral InFectivity and Transmision in HPV positive women before and after vaccination with GARDASIL-9. The effect in oral and anal body fluids and after one or two doses (RIFT-HPV2)
Principal investigator: Bosch FX
Co-investigators: Pavon MA
Ref.: IISP 60552 (RIFT2)
Amount awarded: 140.478, 25EUR
Duration: 2021-2023
State: Awarded

Funding body: INSTITUTO DE SALUD CARLOS III - ISCIII
Project title: Novel human and viral biomarkers to detect anal high-grade intraepithelial lesions and cost-effectiveness analysis among MSM living with HIV
Principal investigator: Paytubi S
Ref.: PI20/01836
Amount awarded: 127.050 EUR
Duration: 2021-2024
State: Awarded

Funding body: INSTITUTO DE SALUD CARLOS III - ISCIII
Project title: ¿Es la vacunación una estrategia adecuada para limitar la infectividad del virus en mujeres positivas para el VPH? (HPV-VIOLIN)
Principal investigator: Pavon MA
Co-investigators: Bosch FX
Ref.: PI20/01819
Amount awarded: 173.030 EUR
Duration: 2021-2025
State: Awarded

Funding body: MSD España
Project title: Reduction of VIral InFectivity and Transmision in HPV positive women before and after vaccination with GARDASIL-9 (RIFT-HPV1)
Principal investigator: Pavon MA
Co-investigators: Bosch FX
Ref.: IISP 59383 (RIFT1)
Amount awarded: 177.148 EUR
Duration: 2020-2023
State: Awarded

Funding body: Ajuntament de l'Hospitalet de Llobregat
Project title: EINA EDUCATIVA PAPILLOMATTACK
Principal investigator: Asensio L
Ref.: PAPILLOMATTACK
Amount awarded: 5.290€
Duration: 2023-2023

Funding body: INSTITUTO DE SALUD CARLOS III - ISCIII
Project title: Contratos Predoctorales de Formación en Investigación en salud (PFIS): Papel de la variabilidad viral, APOBEC y ARNs reguladores de la transcripción en la progresión del carcinoma de vulva asociado a la infección por el virus del papiloma humano 16
Principal investigator: Bosch FX
Ref.: FI18/00244
Amount awarded: 82.400 EUR
Duration: 2019-2023
State: Awarded

Funding body: INSTITUTO DE SALUD CARLOS III - ISCIII
Project title: Identificación de Nuevas Variantes genéticas del Virus del Papiloma Humano-16 ASociadas a la progresión Invasiva del carcinoma de Vulva (VPH16-INVASIV)
Principal investigator: Pavón MA
Co-investigators: Bosch FX
Ref.: PI17/00123
Amount awarded: 75.020 EUR
Duration: 2017-2022
State: Awarded